Farxiga | 合法藥品大搜索

2020年10月21日 — Dapagliflozin(Forxiga)是一個鈉-葡萄糖共同轉運蛋白(sodium-glucose co-​transporter 2，SGLT2)抑制劑，為第二型糖尿病治療藥物，美國FDA ... Read More

at 1-800- 236-9933 or FDA at 1-800-FDA-1088 or ... FARXIGA (dapagliflozin) is indicated as an adjunct to diet and exercise to improve glycemic control in. Read More

To report SUSPECTED ADVERSE REACTIONS, contact AstraZeneca at 1-800-​236-9933 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. ---------------------​-- ... Read More

FARXIGA® (dapagliflozin) tablets, for oral use. eGFR less than 25. Initiation is not ... at 1-800-236-9933 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Read More

FARXIGA (dapagliflozin) is indicated: • as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. • to reduce the risk of ... Read More

2020年5月5日 — Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection ... Read More

2021年4月30日 — Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney ... Read More

Farxiga FDA Approval History. Last updated by Judith ... Last updated by Judith Stewart, BPharm on May 3, 2021. ... Farxiga (dapagliflozin) is a sodium-glucose ... Read More

2020年5月9日 — 2020年5月5日降血糖藥Forxiga (Dapagliflozin)通過美國FDA審核，核准用於收縮功能不全心衰竭病患( heart failure with reduced ejection ... Read More

2021年5月3日 — ACC News Story ... The U.S. Food and Drug Administration (FDA) on May 3 approved dapagliflozin (Farxiga) oral tablets to reduce the risk of ... Read More